Folate vs Folic Acid: Why the Form of B9 You Take Matters More Than You Think
Folate (vitamin B9) is essential for DNA synthesis, DNA repair, and the methylation cycle that drives epigenetic regulation throughout the body. Most supplements and fortified foods contain folic acid — the synthetic, oxidized form that requires metabolic conversion to become biologically active. For the estimated 40 to 60 percent of people with MTHFR genetic variants that slow this conversion, folic acid supplementation may be far less effective than it appears.
- Folate is the generic term for all forms of vitamin B9, including the naturally occurring reduced forms (5-methyltetrahydrofolate, tetrahydrofolate) found in food, and folic acid — the synthetic fully oxidized form used in supplements and fortification. These are not interchangeable in all individuals.
- Folic acid requires the MTHFR (methylenetetrahydrofolate reductase) enzyme to be converted to the biologically active form 5-MTHF (5-methyltetrahydrofolate). Two common MTHFR polymorphisms — C677T and A1298C — reduce this enzyme's activity by 30-65 percent in heterozygous carriers and up to 70 percent in C677T homozygotes. These variants are present in 40-60 percent of the general population.
- The primary consequence of impaired MTHFR activity with folic acid supplementation is reduced 5-MTHF availability for the methylation cycle — reducing SAM production, elevating homocysteine, and potentially impairing the DNA methylation reactions that regulate gene expression. People with MTHFR C677T homozygosity who supplement with folic acid may have persistently elevated homocysteine despite appearing to be supplementing adequately.
- The solution is straightforward: supplement with the active form — 5-methyltetrahydrofolate (5-MTHF, also labeled methylfolate or L-methylfolate) rather than folic acid. 5-MTHF bypasses the MTHFR conversion step entirely and is directly available for the methylation cycle. It is available in most high-quality B complex vitamins and standalone methylfolate supplements.
- Unmetabolized folic acid (UMFA) — which accumulates when folic acid intake exceeds the body's conversion capacity — is an emerging concern. UMFA has been shown to inhibit the cellular folate receptors and potentially interfere with natural killer cell function. High folic acid intake from fortified foods plus supplements in MTHFR variant carriers may produce UMFA accumulation while failing to deliver adequate 5-MTHF.
The distinction between folic acid and methylfolate (5-MTHF) is one of the most practically important nutritional details that most health-conscious adults have never encountered — yet it directly affects a substantial fraction of the population who are supplementing with folic acid under the assumption that they are adequately supporting their methylation cycle, while actually receiving far less benefit than they believe.1
The Folate Metabolism Pathway
Dietary folate from whole foods (leafy vegetables, legumes, liver) exists primarily in the reduced polyglutamated form, which is cleaved to monoglutamate in the gut and then reduced and methylated in the intestinal mucosa before entering circulation as 5-methyltetrahydrofolate (5-MTHF). 5-MTHF is the form that donates methyl groups to the methylation cycle — it donates its methyl group to vitamin B12, which then methylates homocysteine to methionine (the precursor to S-adenosylmethionine, the body's universal methyl donor).2
Folic acid — the synthetic form used in supplements and food fortification since the 1990s (primarily to prevent neural tube defects) — is fully oxidized and must be converted to dihydrofolate (DHF) by dihydrofolate reductase, then to tetrahydrofolate (THF) by DHFR again, then to various reduced folate forms, and ultimately to 5-MTHF by MTHFR. This multi-step conversion pathway is where the MTHFR vulnerability lies.
MTHFR: The Genetic Bottleneck
The MTHFR gene encodes methylenetetrahydrofolate reductase — the enzyme catalyzing the last step of the pathway converting dietary folate to the active 5-MTHF form. Two common single-nucleotide polymorphisms (SNPs) affect this enzyme's activity: the C677T variant reduces MTHFR activity by approximately 35 percent in heterozygotes and 70 percent in homozygotes; the A1298C variant has milder effects but compounds with C677T in compound heterozygotes. These variants are among the most common functionally significant genetic polymorphisms in the human population — C677T homozygosity occurs in approximately 10 to 15 percent of individuals of European and Latino ancestry, and heterozygosity in 40 to 50 percent.3
The clinical consequence: people with MTHFR C677T homozygosity who consume primarily folic acid from supplements and fortified foods have impaired conversion to 5-MTHF, resulting in elevated homocysteine (reflecting inadequate methylation cycle flux), reduced SAM availability for DNA methylation and neurotransmitter synthesis, and potentially accumulation of unmetabolized folic acid (UMFA) in circulation.
Unmetabolized Folic Acid: The Emerging Concern
When folic acid intake exceeds the capacity of the gut and liver to convert it to dihydrofolate, unmetabolized folic acid (UMFA) accumulates in plasma. UMFA has been shown in cell culture and animal studies to inhibit the cellular folate receptor (FOLR1) — the receptor that imports reduced folate forms into cells — and to reduce natural killer cell cytotoxicity. Population studies have found that high circulating UMFA is associated with reduced NK cell activity and worse folate utilization in postmenopausal women, raising concerns that excessive folic acid intake from food fortification plus supplementation may paradoxically impair cellular folate function in susceptible individuals.4
The Practical Solution
The practical solution is straightforward: use the active form. Supplement with 5-methyltetrahydrofolate (5-MTHF, L-methylfolate, or methylfolate — all refer to the same compound) rather than folic acid. 5-MTHF is directly available for the methylation cycle without requiring MTHFR conversion and avoids UMFA accumulation. It is available in most premium B-complex supplements and standalone products under brands including Quatrefolic (5-MTHF glucosamine salt), Metafolin (calcium salt of L-5-MTHF), and generic methylfolate.5
For anyone taking a B vitamin supplement: check whether it contains folic acid or methylfolate (look for 5-MTHF, L-methylfolate, or methylfolate on the label). If it contains folic acid, consider switching to a methylfolate-containing formulation — particularly if you have known MTHFR variants, elevated homocysteine, or are in a life stage where folate demand is high (pregnancy, active cell division, high oxidative stress).
References
- 1Stanger O. "Physiology of folic acid in health and disease." Current Drug Metabolism. 2002;3(2):211-223. [PubMed]
- 2Shane B. "Folate and vitamin B12: function and interaction." Advances in Experimental Medicine and Biology. 1986;206:15-30. [PubMed]
- 3Frosst P, et al. "A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase." Nature Genetics. 1995;10(1):111-113. [PubMed]
- 4Troen AM, et al. "Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women." Journal of Nutrition. 2006;136(1):189-194. [PubMed]
- 5Lamers Y, et al. "Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women." American Journal of Clinical Nutrition. 2006;84(4):763-769. [PubMed]